Biomedical subjects
Publications and source records attributed to U Dold.
Our knowledge about the biology of malignant growth has changed. The tumor cell is not absolutely autonomous. The reactions of the host organism are important (e.g. hormone-dependent tumors). The so-called alternative medicine has always been of this opinion. Some of its methods seem worthy of consideration in cases where surgery, X-ray therapy and cytostatics have doubtful results.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The evaluation of cytostatic chemotherapy is difficult because the criteria are multivarious and the system for testing is complex. The clinical trial only is a reliable method. But the clnical trial require a cooperative study and a cooperative study is very expansive. It is necessary to search for methods less expensive but statistical sufficient.
Explore the source record for details and available documents.
The reality of immunotherapy of cancer is still in the trial stages. Supportive immunotherapy combined with conventional cancer therapy can prolong the duration of remission and perhaps raise the cure rate for many neoplastic diseases such as acute leukemias, sarcomas and malignant melanomas. Our knowledge of the immunologic reactions is still incomplete. We expect further progress but we have no evidence that the immune response will be able to prevent or reverse all malignant growth.